Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation

被引:103
作者
Cheng, IH
Palop, JJ
Esposito, LA
Bien-Ly, N
Yan, FG
Mucke, L [1 ]
机构
[1] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA
关键词
D O I
10.1038/nm1123
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Arctic mutation within the amyloid-(A) peptide causes Alzheimer disease. In vitro, Arctic-mutant A forms (proto) fibrils more effectively than wild-type A. We generated transgenic mouse lines expressing Arctic-mutant human amyloid precursor proteins (hAPP). Amyloid plaques formed faster and were more extensive in Arctic mice than in hAPP mice expressing wild-type A, even though Arctic mice had lower Abeta(1-42/1-40) ratios. Thus, the Arctic mutation is highly amyloidogenic in vivo.
引用
收藏
页码:1190 / 1192
页数:3
相关论文
共 16 条
[1]  
Austen BM, 2000, J PEPT SCI, V6, P459, DOI 10.1002/1099-1387(200009)6:9<459::AID-PSC286>3.0.CO
[2]  
2-B
[3]   Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders [J].
Caughey, B ;
Lansbury, PT .
ANNUAL REVIEW OF NEUROSCIENCE, 2003, 26 :267-298
[4]   Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability [J].
Dahlgren, KN ;
Manelli, AM ;
Stine, WB ;
Baker, LK ;
Krafft, GA ;
LaDu, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (35) :32046-32053
[5]   Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease [J].
DeMattos, RB ;
O'dell, MA ;
Parsadanian, M ;
Taylor, JW ;
Harmony, JAK ;
Bales, KR ;
Paul, SM ;
Aronow, BJ ;
Holtzman, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (16) :10843-10848
[6]   ALZHEIMER-TYPE NEUROPATHOLOGY IN TRANSGENIC MICE OVEREXPRESSING V717F BETA-AMYLOID PRECURSOR PROTEIN [J].
GAMES, D ;
ADAMS, D ;
ALESSANDRINI, R ;
BARBOUR, R ;
BERTHELETTE, P ;
BLACKWELL, C ;
CARR, T ;
CLEMENS, J ;
DONALDSON, T ;
GILLESPIE, F ;
GUIDO, T ;
HAGOPIAN, S ;
JOHNSONWOOD, K ;
KHAN, K ;
LEE, M ;
LEIBOWITZ, P ;
LIEBERBURG, I ;
LITTLE, S ;
MASLIAH, E ;
MCCONLOGUE, L ;
MONTOYAZAVALA, M ;
MUCKE, L ;
PAGANINI, L ;
PENNIMAN, E ;
POWER, M ;
SCHENK, D ;
SEUBERT, P ;
SNYDER, B ;
SORIANO, F ;
TAN, H ;
VITALE, J ;
WADSWORTH, S ;
WOLOZIN, B ;
ZHAO, J .
NATURE, 1995, 373 (6514) :523-527
[7]   Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis [J].
Herzig, MC ;
Winkler, DT ;
Burgermeister, P ;
Pfeifer, M ;
Kohler, E ;
Schmidt, SD ;
Danner, S ;
Abramowski, D ;
Stürchler-Pierrat, C ;
Bürki, K ;
van Duinen, SG ;
Maat-Schieman, MLC ;
Staufenbiel, M ;
Mathews, PM ;
Jucker, M .
NATURE NEUROSCIENCE, 2004, 7 (09) :954-960
[8]   Differential degradation of amyloid β genetic variants associated with hereditary dementia or stroke by insulin-degrading enzyme [J].
Morelli, L ;
Llovera, R ;
Gonzalez, SA ;
Affranchino, JL ;
Prelli, F ;
Frangione, B ;
Ghiso, J ;
Castaño, EM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (26) :23221-23226
[9]   High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice:: Synaptotoxicity without plaque formation [J].
Mucke, L ;
Masliah, E ;
Yu, GQ ;
Mallory, M ;
Rockenstein, EM ;
Tatsuno, G ;
Hu, K ;
Kholodenko, D ;
Johnson-Wood, K ;
McConlogue, L .
JOURNAL OF NEUROSCIENCE, 2000, 20 (11) :4050-4058
[10]   Neurotoxicity and physicochemical properties of Aβ mutant peptides from cerebral amyloid angiopathy -: Implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease [J].
Murakami, K ;
Irie, K ;
Morimoto, A ;
Ohigashi, H ;
Shindo, M ;
Nagao, M ;
Shimizu, T ;
Shirasawa, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (46) :46179-46187